1.Salidroside inhibits osteoclast differentiation based on osteoblast-osteoclast interaction via HIF-1a pathway.
Yutong JIN ; Yao WANG ; Chuan WANG ; Lingling ZHANG ; Dandan GAO ; Haizhao LIU ; Qingwen CAO ; Chenchen TIAN ; Yuhong BIAN ; Yue WANG
Chinese Journal of Natural Medicines (English Ed.) 2025;23(5):572-584
This study investigated the regulatory potential of salidroside (SAL), a primary active compound in Rhodiola rosea L., on osteoclast differentiation by modulating the hypoxia-inducible factor 1-alpha (HIF-1a) pathway in osteoblasts. Luciferase reporter assay and chromatin immunoprecipitation (ChIP) assay were employed to validate whether the receptor activator of nuclear factor-?B ligand (RANKL) is the downstream target gene of HIF-1a in osteoblasts. The study also utilized lipopolysaccharide (LPS)-induced mouse osteolysis to examine the impact of SAL on osteolysis in vivo. Furthermore, conditioned medium (CM) from SAL-pretreated osteoblasts was used to investigate the paracrine effects on osteoclastogenesis through the HIF-1a pathway. Hypoxic condition-induced overexpression of HIF-1a upregulated RANKL levels by binding to the RANKL promoter and enhancing transcription in osteoblastic cells. In vivo, SAL significantly alleviated bone tissue hypoxia and decreased the expression of HIF-1a by downregulating the expression of RANKL, vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), and angiopoietin-like 4 (ANGPTL4). In the paracrine experiment, conditioned media from SAL-pretreated osteoblasts inhibited differentiation through the HIF-1a/RANKL, VEGF, IL-6, and ANGPTL4 pathways. RANKL emerges as the downstream target gene regulated by HIF-1a in osteoblasts. SAL significantly alleviates bone tissue hypoxia and bone loss in LPS-induced osteolysis through the HIF-1a/RANKL, VEGF, IL-6, and ANGPTL4 pathways. SAL inhibits osteoclast differentiation by regulating osteoblast paracrine secretion.
Animals
;
Osteoblasts/cytology*
;
Hypoxia-Inducible Factor 1, alpha Subunit/genetics*
;
Glucosides/administration & dosage*
;
Cell Differentiation/drug effects*
;
Phenols/administration & dosage*
;
Mice
;
Osteoclasts/metabolism*
;
RANK Ligand/genetics*
;
Rhodiola/chemistry*
;
Osteogenesis/drug effects*
;
Signal Transduction/drug effects*
;
Interleukin-6/genetics*
;
Male
;
RAW 264.7 Cells
;
Osteolysis/genetics*
;
Humans
;
Mice, Inbred C57BL
2.Polyunsaturated Fatty Acid Concentrations and Risk of Pneumoconiosis: A Two-sample Mendelian Randomization Study.
Junyi HE ; Chenwei ZHANG ; Yukai ZHANG ; Jingfen ZHANG ; Xuesen SU ; Peiyun HE ; Wenhui BAO ; Haizhao LIU ; Xiao YU ; Yiwei SHI
Biomedical and Environmental Sciences 2024;37(11):1328-1333

Result Analysis
Print
Save
E-mail